PETALING JAYA: Alpha IVF Group Bhd has begun operations at its in-vitro fertilisation (IVF) centre in Quezon City, Manila, marking its second international location after Singapore.
Group managing director Datuk Colin Lee Soon Soo said the company was looking beyond the launch phase and towards operational maturity, adding that the company’s experience in expanding fertility operations in different markets would be applied to Manila.
He said: “We expect the Philippines market to become a significant contributor to our group revenue trajectory from our financial year ending May 31, 2027 (FY27) onwards,”
The centre represents a capital investment of RM9mil, funded with proceeds from its initial public offering.
It is designed to support up to 1,500 procedures annually and will deliver a full suite of reproductive services once it is fully ramped up.
Rather than relying purely on demand growth, the group is also pursuing structural cost savings through engagement with Philippine authorities to obtain fiscal incentives.
This could include income tax exemptions and relief on duties or value added tax, measures that the company expects would improve margins and cash flow if secured.
Manila was chosen for its population density and geographic reach, with the clinic’s location in Quezon City placing it within range of several major urban centres, giving access to an estimated catchment population of more than 20 million people.
The company views this as a market where demand for premium fertility services remains under-served.
Lee said the group’s track record in successfully scaling operations demonstrates its ability to consistently deliver high pregnancy success rates.
“By translating our proven methodologies to Manila, we will replicate the exceptional pregnancy outcomes we are known for.
“We are optimistic that our Manila IVF centre will benefit from the wealth of experience that the group has, catering to the underserved market in the Philippines,” he added.
Alpha IVF reported that its net profit climbed 6.3% year-on-year to RM15.3mil as revenue also increased 21.2% to RM52.1mil for its first quarter ended Aug 31.
The group said it believes it is well-positioned to support the growing demand for assisted reproductive services, driven by global demographic trends, including declining birth rates and changing lifestyle choices that lead to delayed parenthood.
